Brett Leav
Moderna Therapeutics (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Animal Virus Infections Studies, Viral gastroenteritis research and epidemiology, COVID-19 Clinical Research Studies, Influenza Virus Research Studies
Most-Cited Works
- → Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults(2020)1,598 cited
- → Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination(2020)822 cited
- → Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19(2021)745 cited
- → Treatment with Monoclonal Antibodies against Clostridium difficile Toxins(2010)740 cited
- → Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase(2021)653 cited
- → Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis(2021)447 cited
- → Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)(2009)242 cited
- → A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine(2021)231 cited
- → Analysis of Sequence Diversity at the Highly Polymorphic Cpgp40 / 15 Locus among Cryptosporidium Isolates from Human Immunodeficiency Virus-Infected Children in South Africa(2002)170 cited
- → Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees(2012)166 cited